Revolutionising Healthcare in Asia-Pacific
The Impact of Medical Devices on Treatment Delivery
In the dynamic Asia Pacific (APAC) healthcare landscape, innovative solutions are pivotal in transforming healthcare delivery. Medical devices present opportunities to reshape the system, but successful implementation requires addressing regulatory, infrastructure, and training hurdles while prioritising patient well-being. Bijay Singh of DKSH Healthcare highlights how advancements in medical devices like remote monitoring, and self-management apps drive growth in APAC.
Home to 4.3 billion people (60% of the global population), the Asia Pacific (APAC) region presents a rich tapestry of cultures, languages, and socioeconomic backgrounds. From densely populated urban centres boasting state-of-the-art medical facilities, to remote rural communities facing formidable barriers to access, healthcare systems vary widely. Amidst the complexities and opportunities across this landscape, there is a demand for innovative solutions to transform the healthcare delivery system, and this is precisely where medical devices play a crucial role.
Demographic Vulnerabilities
In the APAC region, a significant demographic transformation is underway –the rapid ageing of its population. By 2050, the number of individuals aged 60 and above is projected to more than double, reaching a staggering 1.3 billion or almost 25% of the population.
This demographic trend brings with it a host of healthcare challenges, including an increased burden of age-related diseases and conditions such as cardiovascular diseases, cancer, and neurodegenerative disorders.
Alongside population ageing, there's a marked increase in the prevalence of chronic diseases. Factors contributing to this rise include sedentary lifestyles, unhealthy diets, urbanisation, and environmental factors. Healthcare systems must adapt to provide specialised care for older adults while also addressing their unique healthcare needs, including preventive care, early detection, chronic disease management, and long-term care services. As individuals age, their healthcare needs become more complex, demanding a holistic approach that addresses not just acute ailments but also the multifaceted aspects of ageing, including cognitive health, mobility issues, and social support.
Spurred by this demographic shift, the need for high-quality healthcare continues to rise in the region. This trend is further compounded by the lingering effects of the COVID-19 pandemic and existing resource shortages within healthcare systems. In navigating these healthcare challenges, medical devices play a pivotal role - from advanced monitoring technologies to assistive devices and innovative treatment modalities, medical devices reduce the burden on healthcare professionals, enabling them to deliver tailored and effective care to ageing populations and individuals battling chronic diseases. These devices facilitate early detection, remote monitoring of multiple patients, precise diagnosis, and timely intervention, ultimately improving patient outcomes and enhancing the efficiency of healthcare delivery.
Technological Innovations Driving the Next Frontiers of Growth
Medical devices leverage technology to deliver care safely and efficiently and help strengthen the public health infrastructure. Advanced imaging devices like MRI machines, CT scanners, and ultrasound systems have revolutionised diagnosis by providing detailed insights into internal bodily structures.
For instance, current high-resolution MRI machines enable early detection of tumours, vascular abnormalities, and neurological disorders. Moreover, robotic-assisted surgical systems have enhanced precision while minimising invasiveness. Hospitals across the region utilise these systems for procedures ranging from prostatectomies to cardiac surgeries, resulting in quicker recovery times and reduced complications.
Here's how technologically advanced devices can further contribute to this transformation:
Remote monitoring and telemedicine: Medical devices such as wearable sensors, remote monitoring devices, and telemedicine platforms enable healthcare providers to remotely monitor patients' vital signs, health status, and treatment adherence.
Point-of-care testing: Point-of-care testing devices offer rapid and convenient diagnostic capabilities outside of traditional laboratory settings. These devices can be particularly valuable in resource-limited settings or remote areas. For example, during the COVID-19 pandemic, multiple home-test kits were developed to allow the first round of testing at home. This also helped people adhere to the social distancing norms.
Self-management apps: Mobile health (mHealth) apps and devices empower patients to take an active role in managing their health and well-being. These apps enable users to track their exercise, diet, medication adherence, and vital signs, providing valuable insights into their health status and facilitating communication with healthcare providers. For instance, the Dexcom G6 continuous glucose monitoring system, now available in Singapore and Japan, allows for real-time monitoring, integrated with wearable sensors and a transmitter for the measurement of blood glucose values.
Data-driven decision-making: Medical devices generate vast amounts of patient health data, which can be leveraged to optimise resource allocation and care delivery. By analysing the data trends and patterns in patient populations, healthcare providers can identify areas for improvement, allocate resources more effectively, and implement targeted interventions to address specific healthcare needs. This data-driven approach fosters efficiency, reduces waste, and ultimately lowers healthcare costs.
Home-based care: Technological advancements have facilitated the development of medical devices designed for home use, allowing patients to receive care in the comfort of their own homes rather than in hospitals or long-term care facilities. Home-based care reduces healthcare costs associated with hospitalisations and institutional care while promoting patient independence and quality of life. Devices such as home infusion pumps, portable oxygen concentrators, and remote monitoring systems enable patients with chronic conditions to manage their health outside of traditional healthcare settings, thereby optimising resource allocation and reducing overall healthcare expenditure.
By enabling remote monitoring and telemedicine, emphasising preventive care and chronic disease management, supporting data-driven decision-making, and promoting home-based care, advancements in medical devices hold significant promise for optimising resource allocation and reducing long-term costs.
Key Drivers of Growth
In 2023, the region's medical devices market reached a value of USD 111.93 billion. Projections suggest that it will further grow at a CAGR of 6.8% and reach USD 166.1 billion by 2029. This highlights the considerable potential of the APAC region, characterised by its diverse population. APAC is experiencing strong growth in demand for medical devices, forecast to grow at 7.0% from 2018-2022, surpassing Europe to become the second-largest market globally. Regulatory developments play a crucial role in strengthening the upward growth of this sector. One significant trend is the harmonisation of standards and regulations across key markets such as the Association of Southeast Asian Nations (ASEAN) and North Asia. This effort aims to establish consistent regulatory frameworks, streamline approval processes, and enhance market access for medical devices across borders.
This creates a clearer and more consistent environment for everyone involved, from manufacturers and distributors to healthcare providers and patients.
Leveraging innovative medical devices and technologies, healthcare providers in the APAC region can overcome many barriers to healthcare delivery, such as geographical constraints, resource limitations, and workforce shortages. The interplay of technological advancements, socioeconomic conditions, and the regulatory landscape will ultimately revolutionise healthcare delivery in APAC.
However, successful implementation requires a comprehensive approach that addresses regulatory, infrastructure, reimbursement, and training challenges while ensuring patient privacy, safety, and equity. Collaboration between healthcare stakeholders, technology developers, policymakers, and regulatory authorities is essential to improve health outcomes across the region.
Given the diversity of the Asian market, medical device companies need to leverage access and in-market expertise to thrive. It is imperative for medical device companies to collaborate with trusted strategic healthcare providers who have extensive local regulatory expertise, as such partnerships are crucial for navigating the dynamic regulatory frameworks across Asia. These partnerships will ensure the efficient distribution of medical solutions, optimise resource allocation, and enhance the quality of life in communities
References:
https://asiapacific.unfpa.org/en/populationtrends#:~:text=The%20Asia%20and%20the%20Pacific,Developing%20States%20in%20the%20Pacific.
https://www.nature.com/articles/s41392-022-01251-0
https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354133/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132638/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456103/
https://www.dksh.com/sg-en/home/media/news?id=en-1d9b816a-0a2a-48e5-8d72-5a2f88b381b7:3
https://www.marketdataforecast.com/market-reports/apac-medical-devices-market
https://assets.kpmg.com/content/dam/kpmg/jp/pdf/2020/jp-medical-device-apac-en.pdf
https://asean.org/wp-content/uploads/2023/05/ASEAN-Guidelines-for-Harmonisation-of-Standards-2022-Version.pdf
